Americans left BLIND, paralyzed and with teeth falling out after Ozempic – now they’re suing for millions – Daily Mail
There’s been an all-out push by the drug regulators and media to get every adult and child on Ozempic, a drug which causes temporary weight loss and harms the majority of recipients.
Here, two leading food safety activists expose the staggering corruption behind Ozepmic. A 🧵 pic.twitter.com/fA7NtZTOQi— A Midwestern Doctor (@MidwesternDoc) September 2, 2024
Recent reports have highlighted a surge in lawsuits against the manufacturers of Ozempic, a medication initially developed for diabetes management, due to severe health issues experienced by users. A very close friend of mine recently died from side effects of Ozempic. She ended up with pancreatitis, kidney failure, and ultimately sepsis.
A very close friend of mine recently died from side effects of Ozempic. She ended up with pancreatitis, kidney failure, and ultimately sepsis. pic.twitter.com/emTe8VlP8X
— Dane (@UltraDane) September 6, 2024
What’s wild is that France pays less than 10% of the US price for Ozempic. pic.twitter.com/5NcuZpWajK
— Third_Eye_Prophet (@Third_i_Prophet) November 4, 2024
- Severe Side Effects Reported: Users have reported serious side effects such as stomach paralysis, blindness, and dental issues, including teeth loss.
- Legal Actions Against Manufacturers: Multiple lawsuits have been filed against Novo Nordisk and Eli Lilly, alleging failure to adequately disclose the potential risks associated with Ozempic.
- Case Example: Monica Church, a 55-year-old from Michigan, was prescribed Ozempic in October 2023. By December, she was hospitalized with debilitating stomach issues, including vomiting and stomach paralysis, conditions she was unaware could result from the medication.
- Legal Representation’s Perspective: Attorney Robert King, representing numerous affected patients, noted that gastrointestinal problems are the most common complaints. He also mentioned reports of blood clots, vision loss, and paralysis among users.
- Prevalence of GLP-1 Agonist Usage: A recent poll indicated that approximately one in eight adults in the U.S. are using GLP-1 agonists like Ozempic, suggesting that millions could be at risk of these severe side effects.
